Search Results

Your search for Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD,Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD matches 2 pages

Showing 1 - 2

By Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD / Wednesday, February 6, 2019 6:07 PM

Letter to the Editor: Survey on DOACs in Cancer-Related Venous Thromboembolism

This letter is a follow-up to a report published previously in The ASCO Post. Recent trials report comparable or improved efficacy of direct-acting oral coagulants (DOACs) over low–molecular-weight heparins (LMWH) in the treatment of cancer-related VTE (cVTE) at the expense of increased...

symptom management

By Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD / December 25, 2018

Clinician Survey to Explore Direct-Acting Oral Anticoagulants vs Low–Molecular-Weight Heparin in Cancer-Related VTE

Injectable low–molecular-weight heparin has long been considered the standard of care for treatment of venous thromboembolism (VTE) in patients with cancer. However, low–molecular-weight heparin is costly and often disliked by patients due to injection-related discomfort and bruising....

Nov

Today In Oncology

Search Results

Your search for Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD,Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD matches 2 pages

Letter to the Editor: Survey on DOACs in Cancer-Related Venous Thromboembolism

Clinician Survey to Explore Direct-Acting Oral Anticoagulants vs Low–Molecular-Weight Heparin in Cancer-Related VTE

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC